Viewing Study NCT00148720


Ignite Creation Date: 2025-12-25 @ 4:12 AM
Ignite Modification Date: 2026-07-09 @ 8:40 AM
Study NCT ID: NCT00148720
Status: TERMINATED
Last Update Posted: 2015-11-11
First Post: 2005-09-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Capecitabine in Women With Operable Breast Cancer
Sponsor: Dana-Farber Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Invasive Breast Carcinoma View
None Primary Invasive Breast Cancer View
None Stage I Breast Cancer View
None Stage II Breast Cancer View
None Stage III Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Invasive Breast Cancer View
None Operable Breast Cancer View
None Capecitabine View